1594 |
English |
Role of LSG in TB Elimination |
Published on LMS |
Link |
PoulamiM |
PrashantBhat |
3 weeks |
1594 |
Gujarati |
Role of LSG in TB Elimination |
Published on LMS |
Link |
PoulamiM |
PrashantBhat |
3 weeks |
1594 |
Marathi |
Role of LSG in TB Elimination |
Published on LMS |
Link |
PoulamiM |
PrashantBhat |
3 weeks |
1594 |
Telugu |
Role of LSG in TB Elimination |
Published on LMS |
Link |
PoulamiM |
PrashantBhat |
3 weeks |
6911 |
English |
Peripheral Neuropathy |
Depreciated |
|
Shahnawaz |
RakeshPS |
2 weeks 5 days |
6903 |
English |
WHO recommendation for newer, shorter, oral regimens |
Final Review |
|
NimishaArora |
Abhimanyu |
2 weeks 4 days |
6905 |
English |
BPaLM regimen for DR-TB |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6906 |
English |
Newer Anti-TB Drugs: Pretomanid [Pa] |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6908 |
English |
Rationale for continuation of Moxifloxacin in BPaLM regimen irrespective of FQ resistance |
Final Review |
|
NimishaArora |
Abhimanyu |
2 weeks 4 days |
6916 |
English |
Evidence for the efficacy of BPaL regimen in DR-TB |
Final Review |
|
NimishaArora |
Abhimanyu |
2 weeks 4 days |
6915 |
English |
Peripheral neuropathy screening tool |
Under Development |
|
Shahnawaz |
RakeshPS |
2 weeks 4 days |
6919 |
English |
Overview of Treatment Course for patients on BPaLM regimen |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6902 |
English |
Eligibility Criteria for BPaLM |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6920 |
English |
Management of BPaLM ineligible patients |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
1821 |
English |
History of Programmatic Management of Drug Resistant TB [PMDT] in India |
Published on LMS |
Link |
NimishaArora |
Abhimanyu |
2 weeks 4 days |
6907 |
English |
Relative contraindications Criteria for BPaLM |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6921 |
English |
Regimen modification for patients on BPaLM regimen |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6952 |
English |
Ambulatory care for DR-TB patients |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6918 |
English |
Pregnancy and Lactation |
Under Development |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6951 |
English |
Reconstitution of PwB for BPaLM regimen |
Final Review |
|
NimishaArora |
Abhimanyu |
2 weeks 4 days |
6923 |
English |
Extension criterion for BPaLM regimen |
Final Review |
|
NimishaArora |
RakeshPS |
2 weeks 4 days |
6914 |
English |
Long term follow-up for DR-TB treatment |
Final Review |
|
sankar.anand@theunion.org |
Abhimanyu |
2 weeks 4 days |
6909 |
English |
DAIDS scale for assessment of Peripheral Neuropathy |
Final Review |
|
Shahnawaz |
RakeshPS |
2 weeks 3 days |
3215 |
English |
Burden of DR-TB in India |
Final Review |
|
NimishaArora |
PrashantBhat |
2 weeks 3 days |
6961 |
English |
2024 Updates in DR-TB Management |
Under Development |
|
NimishaArora |
Abhimanyu |
2 weeks 3 days |
6904 |
English |
2024 NTEG Recommendations for DR-TB Management |
Final Review |
|
NimishaArora |
Abhimanyu |
2 weeks 3 days |
6955 |
English |
Management of DR-TB Treatment interruptions |
Final Review |
|
shwetamurthy625@gmail.com |
Abhimanyu |
2 weeks 3 days |
6933 |
English |
TB Disease Severity considerations for Management |
Final Review |
|
NimishaArora |
Abhimanyu |
2 weeks 3 days |
1816 |
English |
Management of Hepato-toxicity During treatment with MDR/RR-TB Regimen |
Final Review |
Link |
shwetamurthy625@gmail.com |
Abhimanyu |
2 weeks 3 days |
6959 |
English |
Management of ADRs - DR-TB Treatment |
Page Prioritised |
|
Shahnawaz |
RakeshPS |
2 weeks 3 days |
6957 |
English |
Management DR-TB in Special Situations - People with anemia |
Page Prioritised |
|
Shahnawaz |
RakeshPS |
2 weeks 3 days |
6943 |
English |
Management DR-TB in Special Situations - People with Diabetes Mellitus |
Page Prioritised |
|
RakeshPS |
RakeshPS |
2 weeks 3 days |
6937 |
English |
Management DR-TB in Special Situations - different age groups |
Page Prioritised |
|
Shahnawaz |
RakeshPS |
2 weeks 3 days |
6945 |
English |
Management DR-TB in Special Situations |
Page Prioritised |
|
Shahnawaz |
RakeshPS |
2 weeks 2 days |
6940 |
English |
Management DR-TB in Special Situations - People with Liver disease |
Page Prioritised |
|
Shahnawaz |
RakeshPS |
2 weeks 2 days |
6927 |
English |
Packaging of BPaLM regimen and PwB |
Final Review |
|
sankar.anand@theunion.org |
Abhimanyu |
2 weeks 2 days |
6928 |
English |
Issue of BPaLM regimen PwBs |
Final Review |
|
sankar.anand@theunion.org |
Abhimanyu |
2 weeks 2 days |
6935 |
English |
Management of DR-TB in people living with HIV |
Final Review |
|
Shahnawaz |
RakeshPS |
2 weeks 2 days |
6938 |
English |
Principles of Switching from BpalL/ Shorter Oral Regimen to Longer Oral Regimen |
Under Development |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6956 |
English |
Principles of Switching to BPal from Shorter Oral Regimen |
Page Prioritised |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6926 |
English |
Discordance resolution in RR between LPA and NAAT |
Under Development |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6913 |
English |
Treatment initiation for MDR/RR-TB cases |
Final Review |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6922 |
English |
Implementation Consideration for BPaLM regimen |
Final Review |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6932 |
English |
Regimen Modification of Shorter Oral MDR/RR regimen containing Bdq and Lnz |
Under Development |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6949 |
English |
Scenarios for deciding for DR-TB Regimen |
Final Review |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
6941 |
English |
Refreshing BDQ course after switching between regimens |
Under Development |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 2 days |
1814 |
English |
Additional Monitoring During Pregnancy and Lactation in Women on Shorter/Longer Oral MDR-TB Regimen |
Final Review |
Link |
Dr. Priyadarshini |
Abhimanyu |
2 weeks 2 days |
1052 |
English |
Management of QT Prolongation by Grade of Severity of ADR |
Final Review |
Link |
Dr. Priyadarshini |
Abhimanyu |
2 weeks 2 days |
1572 |
English |
Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Patients with Renal Impairment |
Final Review |
Link |
NimishaArora |
Abhimanyu |
2 weeks 1 day |
6924 |
English |
Screening of patients on BPaLM regimen for Linezolid toxicity |
Under Development |
|
Nikita.Srivastava |
RakeshPS |
2 weeks 1 day |